Glenn M. Chertow

Publication Details

  • On the relative safety of parenteral iron formulations.

    Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J. Nephrol Dial Transplant. 2004; 19 (6): 1571-5

    Intravenous iron is usually required to optimize the correction of anaemia in persons with advanced chronic kidney disease and end-stage renal disease. Randomized clinical trials may have insufficient power to detect differences in the safety profiles of specific formulations.

    PubMedID: 15150356

Stanford Medicine Resources:

Footer Links: